Source:http://linkedlifedata.com/resource/pubmed/id/15371767
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4 Pt 2
|
| pubmed:dateCreated |
2004-9-16
|
| pubmed:abstractText |
Recent data suggest that aldosterone directly mediates cardiac fibrosis and hypertensive nephrosclerosis. We conducted experiments to determine whether administration of spironolactone, a mineralocorticoid receptor antagonist, reduced renal fibrosis in an experimental model of obstructive uropathy.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Oct
|
| pubmed:issn |
0022-5347
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
172
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1590-4
|
| pubmed:meshHeading |
pubmed-meshheading:15371767-Aldosterone Antagonists,
pubmed-meshheading:15371767-Animals,
pubmed-meshheading:15371767-Fibrosis,
pubmed-meshheading:15371767-Kidney,
pubmed-meshheading:15371767-Male,
pubmed-meshheading:15371767-Mice,
pubmed-meshheading:15371767-Mice, Inbred C57BL,
pubmed-meshheading:15371767-Spironolactone
|
| pubmed:year |
2004
|
| pubmed:articleTitle |
Prevention of renal fibrosis by spironolactone in mice with complete unilateral ureteral obstruction.
|
| pubmed:affiliation |
Department of Pediatrics, Schneider Children's Hospital, New Hyde Park, New York 11040, USA. trachtma@lij.edu
|
| pubmed:publicationType |
Journal Article
|